Article Versions Notes

Consalvo S, Hinterwimmer F, Harrasser N, Lenze U, Matziolis G, von Eisenhart-Rothe R, Knebel C. C-Reactive Protein Pretreatment-Level Evaluation for Ewing’s Sarcoma Prognosis Assessment—A 15-Year Retrospective Single-Centre Study. Cancers. 2022; 14(23):5898. https://doi.org/10.3390/cancers14235898

Consalvo, Sarah, Florian Hinterwimmer, Norbert Harrasser, Ulrich Lenze, Georg Matziolis, Rüdiger von Eisenhart-Rothe, and Carolin Knebel. 2022. "C-Reactive Protein Pretreatment-Level Evaluation for Ewing’s Sarcoma Prognosis Assessment—A 15-Year Retrospective Single-Centre Study" Cancers 14, no. 23: 5898. https://doi.org/10.3390/cancers14235898

Consalvo, S., Hinterwimmer, F., Harrasser, N., Lenze, U., Matziolis, G., von Eisenhart-Rothe, R., & Knebel, C. (2022). C-Reactive Protein Pretreatment-Level Evaluation for Ewing’s Sarcoma Prognosis Assessment—A 15-Year Retrospective Single-Centre Study. Cancers, 14(23), 5898. https://doi.org/10.3390/cancers14235898